SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on Wednesday, September 9, at 9:35 a.m. Eastern Time at the Rodman & Renshaw 17th Annual Global Investment Conference in New York. A webcast of the company's presentation will be available live and archived through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.
CONTACT: Andrew Hopkins (858) 646-1127 Website: www.vical.com